Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...
Capital Market on MSN
Biocons arm inks pact to commercialize biosimilar Aflibercept Worldwide
The agreement clears the way for Biocon Biologics to commercialize Yesafili globally. Yesafili is a vascular endothelial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback